Effects of obesity on pharmacokinetics implications for drug therapy (Q34053786)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Effects of obesity on pharmacokinetics implications for drug therapy	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

review article

1 reference

stated in

Europe PubMed Central

title

Effects of obesity on pharmacokinetics implications for drug therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

main subject

obesity

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Cheymol G

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

publication date

1 September 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

published in

Clinical Pharmacokinetics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

volume

39

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

page(s)

215-231

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

cites work

Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of obesity and disease on busulfan oral clearance in adults

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of vancomycin in a morbidly obese patient

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of acute and chronic exercise on hepatic drug metabolism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic considerations in obesity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lithium pharmacokinetics in the obese

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time trends in obesity: an epidemiological perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Increase in the prevalence of obesity among children aged 4-5 years in a French district between 1988 and 1993]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracycline antibiotic pharmacology and metabolism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of sufentanil in obese patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenytoin disposition in obesity. Determination of loading dose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of theophylline in obesity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluconazole serum concentrations and pharmacokinetics in an obese patient

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lean body mass in obesity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous ciprofloxacin dosing in a morbidly obese patient

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lean body mass as a predictor of drug dosage. Implications for drug therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in overweight among US adults from 1987 to 1993: a multistate telephone survey

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of dexfenfluramine in obese and non-obese subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbamazepine pharmacokinetics in obese and lean subjects.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity and cardiac function

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of drugs in obesity. An update

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of fluoxetine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucytosine dosing in an obese patient with extrameningeal cryptococcal infection.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vancomycin pharmacokinetics in normal and morbidly obese subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant weight reduction in obese subjects enhances carbamazepine elimination

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) in women and obese men compared with normal-sized men

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors that may effect the reduction of hunger and body weight following d-fenfluramine administration.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin clearance in the obese

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenytoin and plasmapheresis: importance of sampling times and impact of obesity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and Pharmacodynamics of Triazolam After Two Intermittent Doses in Obese and Normal-Weight Men

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in the prevalence of obesity in the French adult population between 1980 and 1991

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous ciprofloxacin disposition in obesity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of propranolol and sotalol pharmacokinetics in obese subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vancomycin dosing in morbidly obese patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to predict carboplatin clearance from standard morphological and biological characteristics in obese patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of sevoflurane.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caffeine pharmacokinetics in obesity and following significant weight reduction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11020136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003088-200039030-00004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

Dimensions Publication ID

1030572913

0 references

PubMed publication ID

11020136

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11020136

retrieved

30 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34053786&oldid=2196178650"